Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance-Reference-Cited by-同舟云学术

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

Published:2008-09-02 Issue:2 Volume:12 Page:143-147
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Jhavar S,Bartlett J,Kovacs G,Corbishley C,Dearnaley D,Eeles R,Khoo V,Huddart R,Horwich A,Thompson A,Norman A,Brewer D,Cooper C S,Parker C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan200847.pdf

Reference22 articles.

1. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–1984.

2. Albertsen P, Gleason D, Barry M . Competing risk analysis of men aged 55–74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975–980.

3. Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002; 167: 1664–1669.

4. Klotz LH, Choo R, Morton G, Danjoux C . Expectant management with selective delayed intervention for favorable-risk prostate cancer. Can J Urol 2002; 9 (Suppl 1): 2–7.

5. Parker CC . Re: long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004; 96: 1480; author reply 1480–1481.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions;Surgical and Experimental Pathology;2024-08-20

2. Biomarkers in Urinary Tract and Male Genital System Carcinomas;Biomarkers in Carcinoma of Unknown Primary;2022

3. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer;American Journal of Surgical Pathology;2020-02-10

4. The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and Therapy;Advances in Anatomic Pathology;2019-09-09

5. New Histopathological & Genetic Features to Improve Active Surveillance Selection for Low-Risk Prostate Cancer;Anti-Cancer Agents in Medicinal Chemistry;2018-11-30